Omnicell Share Price Today
(NASDAQ: OMCL)

Name: Omnicell Share Price Today (NASDAQ: OMCL) - Omnicell Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Omnicell share price is $44.66 & ₹3,865.10 as on 31 Jan 2025, 2.30 'hrs' IST

$44.66

▲

-0.23

(-0.51%)

Market is closed - opens 8 PM, 30 Jan 2025

View live Omnicell share price in Dollar and Rupees. Guide to invest in Omnicell stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Omnicell, along with analyst recommendations, forecasts, and comprehensive financials.

Omnicell share price movements

Today's Low: $44.26
Today's High: $44.98
$44.66
0.9%
Downside
Day's Volatility :1.6%
Upside
0.71%
52 Weeks Low: $25.12
52 Weeks High: $55.75
$44.66
43.75%
Downside
52 Weeks Volatility :54.94%
Upside
19.89%

Omnicell (OMCL) Returns

Period	Omnicell Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.71%	-1.3%	0.0%
6 Months	15.55%	-2.4%	0.0%
1 Year	39.54%	4.5%	0.0%
3 Years	-70.1%	12.3%	-10.1%

Omnicell (OMCL) Key Statistics

in dollars & INR

Previous Close	$44.89
Open	$44.78
Today's High	$44.98
Today's Low	$44.26
Market Capitalization	$2.1B
Today's Volume	$447.4K
52 Week High	$55.745
52 Week Low	$25.12
Revenue TTM	$1.1B
EBITDA	$26.5M
Earnings Per Share (EPS)	$-0.39
Profit Margin	-1.66%
Quarterly Earnings Growth YOY	0.56%
Return On Equity TTM	-1.46%

How to invest in Omnicell Stock (OMCL) from India?

It is very easy for Indian residents to invest directly in Omnicell from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Omnicell stock in both Indian Rupees (INR) and US Dollars (USD). Search for Omnicell or OMCL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Omnicell or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Omnicell shares which would translate to 0.019 fractional shares of Omnicell as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Omnicell, in just a few clicks!

Returns in Omnicell (OMCL) for Indian investors in Rupees

The Omnicell stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Omnicell investment value today

Current value as on today

₹1,42,946

Returns

₹42,946

(+42.95%)

Returns from Omnicell Stock

₹38,825 (+38.82%)

Dollar Returns

₹4,121 (+4.12%)

Indian investors sentiment towards Omnicell (OMCL)

-13%

Period: Dec 30, 2025 to Jan 29, 2025. Change in 30 Days versus previous period

Search interest for Omnicell Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Omnicell

BlackRock Inc
18.06%
Vanguard Group Inc
11.95%
State Street Corp
4.90%
Champlain Investment Partners, LLC
3.34%
Dimensional Fund Advisors, Inc.
2.69%
Pacer Advisors, INC.
2.69%

Analyst Recommendation on Omnicell

Buy

60%Buy

33%Hold

6%Sell

Based on 15 Wall street analysts offering stock ratings for Omnicell(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Omnicell Stock (OMCL)

What analysts predicted

Upside of 21.23%

Target:

$54.14

Current:

$44.66

Insights on Omnicell Stock (Ticker Symbol: OMCL)

Price Movement
In the last 6 months, OMCL stock has moved up by 58.3%
Increasing Revenue
Revenue is up for the last 3 quarters, 246.15M → 282.42M (in $), with an average increase of 6.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -15.67M → 8.63M (in $), with an average increase of 288.2% per quarter
OMCL vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 95.9% return, outperforming this stock by 67.4%
OMCL vs HQY (3 yr)
In the last 3 years, Healthequity Inc has given 36.9% return, outperforming this stock by 106.6%
Price to Sales
ForOMCL every $1 of sales, investors are willing to pay $1.9, whereas for Doximity, Inc., the investors are paying $20.6 for every $1 of sales.

OMCL Omnicell Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$787.3M	↑ 9.93%
Net Income	$37.7M	↑ 83.11%
Net Profit Margin	4.79%	↑ 1.91%

	FY19	Y/Y Change
Revenue	$897.0M	↑ 13.94%
Net Income	$61.3M	↑ 62.58%
Net Profit Margin	6.84%	↑ 2.05%

	FY20	Y/Y Change
Revenue	$892.2M	↓ 0.54%
Net Income	$32.2M	↓ 47.51%
Net Profit Margin	3.61%	↓ 3.23%

	FY21	Y/Y Change
Revenue	$1.1B	↑ 26.88%
Net Income	$77.8M	↑ 141.81%
Net Profit Margin	6.88%	↑ 3.27%

	FY22	Y/Y Change
Revenue	$1.3B	↑ 14.48%
Net Income	$5.6M	↓ 92.74%
Net Profit Margin	0.44%	↓ 6.44%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 11.48%
Net Income	$-20.4M	↓ 460.68%
Net Profit Margin	-1.78%	↓ 2.22%

	Q2 FY23	Q/Q Change
Revenue	$299.0M	↑ 2.87%
Net Income	$3.5M	↓ 123.01%
Net Profit Margin	1.15%	↑ 6.31%

	Q3 FY23	Q/Q Change
Revenue	$298.7M	↓ 0.1%
Net Income	$5.6M	↑ 60.91%
Net Profit Margin	1.86%	↑ 0.71%

	Q4 FY23	Q/Q Change
Revenue	$258.8M	↓ 13.33%
Net Income	$-14.4M	↓ 358.87%
Net Profit Margin	-5.55%	↓ 7.41%

	Q1 FY24	Q/Q Change
Revenue	$246.2M	↓ 4.9%
Net Income	$-15.7M	↑ 9.05%
Net Profit Margin	-6.37%	↓ 0.82%

	Q2 FY24	Q/Q Change
Revenue	$276.8M	↑ 12.45%
Net Income	$3.7M	↓ 123.83%
Net Profit Margin	1.35%	↑ 7.72%

	Q3 FY24	Q/Q Change
Revenue	$282.4M	↑ 2.03%
Net Income	$8.6M	↑ 131.06%
Net Profit Margin	3.06%	↑ 1.71%

	FY18	Y/Y Change
Profit	$372.3M	↑ 15.6%

	FY19	Y/Y Change
Profit	$436.9M	↑ 17.35%

	FY20	Y/Y Change
Profit	$413.3M	↓ 5.41%

	FY21	Y/Y Change
Profit	$554.7M	↑ 34.2%

	FY22	Y/Y Change
Profit	$589.0M	↑ 6.19%

	FY23	Y/Y Change
Profit	$496.8M	↓ 15.64%

	Q2 FY23	Q/Q Change
Profit	$134.4M	↑ 7.53%

	Q3 FY23	Q/Q Change
Profit	$132.0M	↓ 1.84%

	Q4 FY23	Q/Q Change
Profit	$105.4M	↓ 20.13%

	Q1 FY24	Q/Q Change
Profit	$95.3M	↓ 9.57%

	Q2 FY24	Q/Q Change
Profit	$114.4M	↑ 19.97%

	Q3 FY24	Q/Q Change
Profit	$122.3M	↑ 6.92%

	FY18	Y/Y Change
Operating Cash Flow	$104.0M	↑ 318.64%
Investing Cash Flow	$-54.4M	↑ 55.41%
Financing Cash Flow	$-13.6M	↑ 37.66%

	FY19	Y/Y Change
Operating Cash Flow	$145.0M	↑ 39.48%
Investing Cash Flow	$-61.7M	↑ 13.41%
Financing Cash Flow	$-23.5M	↑ 72.68%

	FY20	Y/Y Change
Operating Cash Flow	$185.9M	↑ 28.18%
Investing Cash Flow	$-279.9M	↑ 353.86%
Financing Cash Flow	$456.3M	↓ 2043.31%

	FY21	Y/Y Change
Operating Cash Flow	$231.8M	↑ 24.72%
Investing Cash Flow	$-412.5M	↑ 47.39%
Financing Cash Flow	$47.4M	↓ 89.62%

	FY22	Y/Y Change
Operating Cash Flow	$77.8M	↓ 66.45%
Investing Cash Flow	$-58.7M	↓ 85.78%
Financing Cash Flow	$-21.0M	↓ 144.24%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$72.9M	↑ 470.89%
Investing Cash Flow	$-14.8M	↑ 8.63%
Financing Cash Flow	$3.6M	↓ 6.71%

Omnicell Technicals Summary

Sell

Neutral

Buy

Omnicell is currently in a neutral trading position according to technical analysis indicators.

Omnicell (OMCL) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Omnicell Inc	3.62%	15.55%	39.54%	-70.1%	-45.42%
Doximity, Inc.	6.86%	108.58%	111.99%	25.37%	7.79%
Solventum Corp	13.37%	28.97%	8.36%	8.36%	8.36%
Ge Healthcare Technologies Inc.	11.68%	5.25%	19.66%	45.11%	45.11%
Veeva Systems Inc.	9.82%	22.79%	11.97%	-1.82%	56.3%
Healthequity Inc	12.26%	38.32%	42.51%	101.55%	60.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Omnicell Inc	470.14	NA	2.28	1.69	-0.01	-0.01	NA	26.59
Doximity, Inc.	63.62	63.62	2.42	1.15	0.19	0.12	NA	5.15
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Ge Healthcare Technologies Inc.	24.38	24.38	9.58	4.28	0.22	0.06	0.0	18.2
Veeva Systems Inc.	55.88	55.88	1.25	6.45	0.13	0.06	NA	28.8
Healthequity Inc	95.72	95.72	1.17	3.15	0.05	0.03	NA	23.63

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Omnicell Inc	Buy	$2.1B	-45.42%	470.14	-1.66%
Doximity, Inc.	Hold	$10.3B	7.79%	63.62	33.69%
Solventum Corp	Hold	$10.8B	8.36%	NA	15.73%
Ge Healthcare Technologies Inc.	Buy	$40.7B	45.11%	24.38	8.56%
Veeva Systems Inc.	Buy	$36.7B	56.3%	55.88	23.91%
Healthequity Inc	Buy	$9.0B	60.33%	95.72	9.61%

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Organization	Omnicell
Employees	3660
CEO	Mr. Randall A. Lipps
Industry	Technology Services

Management People of Omnicell

Name	Title
Mr. Randall A. Lipps	Founder, Executive Chairman, President & CEO
Mr. Nchacha E. Etta	Executive VP & CFO
Mr. Corey J. Manley	Executive VP, Chief Legal & Administrative Officer and Corporate Secretary
Mr. Nnamdi Njoku	Executive VP & COO
Mr. Brian H. Nutt	VP, Chief Accounting Officer & Corporate Controller
Mr. Giri Chodavarapu	Senior VP & Chief Information Officer
Ms. Kathleen Nemeth	Senior Vice President of Investor Relations
Mr. Maximo Rocha	Senior VP & Chief People Officer
Ms. Minoo Mortazavi	Senior Vice President of Global Operations
Ms. Sara Dalmasso	Senior VP & GM of International

Important FAQs about investing in OMCL Stock from India :

What is Omnicell share price today?

Omnicell share price today stands at $44.66, Open: $44.78 ; Previous Close: $44.89 ; High: $44.98 ; Low: $44.26 ; 52 Week High: $55.75 ; 52 Week Low: $25.12. The stock opens at $44.78, after a previous close of $44.89. The stock reached a daily high of $44.98 and a low of $44.26, with a 52-week high of $55.75 and a 52-week low of $25.12.

Can Indians buy Omnicell shares?

Yes, Indians can invest in the Omnicell (OMCL) from India.

With INDmoney, you can buy Omnicell at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Omnicell at zero transaction cost.

How can I buy Omnicell shares from India?

It is very easy to buy Omnicell from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Omnicell (OMCL) be purchased?

Yes, you can buy fractional shares of Omnicell with INDmoney app.

What are the documents required to start investing in Omnicell stocks?

To start investing in Omnicell, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.